Celgene Corporation (NASDAQ:CELG) announced that the Board of Directors voted to recommend a two-for-one split of the Company’s common stock to be effected through an Amendment to the Company’s Certificate of Incorporation. Celgene Corporation (NASDAQ:CELG) open in the last session at $163.07 and closed at $163.17, the stock showed a positive weekly performance of 1.93%.
VIVUS, Inc. (NASDAQ:VVUS)announced that it will report financial results for the fourth quarter and year ended December 31, 2013 after the NASDAQ Market closes on Monday, February 24, 2014. VIVUS, Inc.(NASDAQ:VVUS) 52 week range is $6.43 – $15.62. Company’s market capitalization is $686.15M.
Clovis Oncology (NASDAQ:CLVS) had its target price boosted by Mizuho from $90.00 to $100.00 in a report issued on 29 January, Stock Ratings Network.com reports. They currently have a buy rating on the stock. Clovis Oncology Inc. (NASDAQ:CLVS) finished the last session at $72.58. The EPS of the stock remained-2.81. Company’s market capitalization is $2.18B.
Pfizer Inc. (NYSE:PFE) has three out of six late-stage drugs intended for cancer treatments and this reveals the new strategy that the company has recently adopted. Pfizer Inc.(NYSE:PFE) closed the last session at $31.46. Pfizer Inc. (NYSE:PFE) 52 week range is $26.82 – $32.50.